{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:41:22Z","timestamp":1792636882866,"version":"4.5.0"},"reference-count":73,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:sec id=\"ab-srv230009-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Liver malignancies are an increasing global health concern with a high mortality. We review outcomes following liver transplant for primary and secondary hepatic malignancies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-srv230009-2\">\n                    <jats:title>Observations<\/jats:title>\n                    <jats:p>Transplant may be a suitable treatment option for primary and secondary hepatic malignancies in well-selected patient populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-srv230009-3\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Many patients with primary or secondary liver tumors are not eligible for liver resection because of advanced underlying liver disease or high tumor burden, precluding complete tumor clearance. Although liver transplant has been a long-standing treatment modality for patients with hepatocellular carcinoma, recently transplant has been considered for patients with other malignant diagnoses. In particular, while well-established for hepatocellular carcinoma and select patients with perihilar cholangiocarcinoma, transplant has been increasingly used to treat patients with intrahepatic cholangiocarcinoma, as well as metastatic disease from colorectal liver and neuroendocrine primary tumors. Because of the limited availability of grafts and the number of patients on the waiting list, optimal selection criteria must be further defined. The ethics of organ allocation to individuals who may benefit from prolonged survival after transplant yet have a high incidence of recurrence, as well as the role of living donation, need to be further discerned in the setting of transplant oncology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamasurg.2023.6083","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T11:01:27Z","timestamp":1701860487000},"page":"211","source":"Crossref","is-referenced-by-count":29,"title":["Liver Transplant as a Treatment of Primary and Secondary Liver Neoplasms"],"prefix":"10.1001","volume":"159","author":[{"given":"Leva","family":"Gorji","sequence":"first","affiliation":[{"name":"Department of Surgery, Kettering Health Dayton, Dayton, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary J.","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, New York University\u2013Long Island, Mineola"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Limkemann","sequence":"additional","affiliation":[{"name":"Division of Transplant, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin D.","family":"Schenk","sequence":"additional","affiliation":[{"name":"Division of Transplant, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, James Cancer Hospital, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"srv230009r1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000517328","article-title":"Liver transplantation in malignancies: a comprehensive and systematic review on oncological outcome.","volume":"37","author":"Talakic","year":"2021","journal-title":"Visc Med"},{"issue":"18","key":"srv230009r2","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.3748\/wjg.v20.i18.5345","article-title":"Liver transplantation for hepatic tumors: a systematic review.","volume":"20","author":"Ravaioli","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"11","key":"srv230009r3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"issue":"1","key":"srv230009r4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/cld.793","article-title":"What are the optimal liver transplantation criteria for hepatocellular carcinoma?","volume":"13","author":"Mehta","year":"2019","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"18","key":"srv230009r5","first-page":"1227","article-title":"Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan criteria [in Chinese].","volume":"86","author":"Fan","year":"2006","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"11","key":"srv230009r6","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1111\/j.1600-6143.2007.01965.x","article-title":"Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging.","volume":"7","author":"Yao","year":"2007","journal-title":"Am J Transplant"},{"issue":"1","key":"srv230009r7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/SLA.0b013e31820508f1","article-title":"Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion.","volume":"253","author":"DuBay","year":"2011","journal-title":"Ann Surg"},{"issue":"1","key":"srv230009r8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/hep.27787","article-title":"Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: a prospective validation.","volume":"62","author":"Toso","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"srv230009r9","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/SLA.0000000000001578","article-title":"Serum tumor markers provide refined prognostication in selecting liver transplantation candidate for hepatocellular carcinoma patients beyond the Milan criteria.","volume":"263","author":"Lee","year":"2016","journal-title":"Ann Surg"},{"issue":"1","key":"srv230009r10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1053\/j.gastro.2017.09.025","article-title":"Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma.","volume":"154","author":"Mazzaferro","year":"2018","journal-title":"Gastroenterology"},{"issue":"11","key":"srv230009r11","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1002\/(ISSN)1527-6473","article-title":"Results of liver transplantation: with or without Milan criteria?","volume":"13","author":"Mazzaferro","year":"2007","journal-title":"Liver Transpl"},{"issue":"3","key":"srv230009r12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update.","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"issue":"12","key":"srv230009r13","doi-asserted-by":"publisher","first-page":"7231","DOI":"10.1245\/s10434-022-12242-4","article-title":"Critical analysis of the updated Barcelona Clinic Liver Cancer (BCLC) group guidelines.","volume":"29","author":"Tsilimigras","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"srv230009r14","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1002\/hep.27752","article-title":"Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria.","volume":"61","author":"Yao","year":"2015","journal-title":"Hepatology"},{"issue":"8","key":"srv230009r15","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1097\/00007890-200004270-00019","article-title":"Liver transplantation for cholangiocarcinoma: results in 207 patients.","volume":"69","author":"Meyer","year":"2000","journal-title":"Transplantation"},{"issue":"4","key":"srv230009r16","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S1072-7515(98)00207-5","article-title":"Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation.","volume":"187","author":"Iwatsuki","year":"1998","journal-title":"J Am Coll Surg"},{"issue":"2","key":"srv230009r17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/01.sla.0000108702.45715.81","article-title":"Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma.","volume":"239","author":"Robles","year":"2004","journal-title":"Ann Surg"},{"issue":"5","key":"srv230009r18","doi-asserted-by":"publisher","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","article-title":"Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology.","volume":"19","author":"Benson","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"srv230009r19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156127","article-title":"Strict selection alone of patients undergoing liver transplantation for hilar cholangiocarcinoma is associated with improved survival.","volume":"11","author":"Mantel","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"srv230009r20","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S2468-1253(21)00219-3","article-title":"Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato Biliary Association consensus guidelines.","volume":"6","author":"Bonney","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"srv230009r21","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1111\/ajt.13831","article-title":"The long-term benefit of liver transplantation for hepatic metastases from neuroendocrine tumors.","volume":"16","author":"Mazzaferro","year":"2016","journal-title":"Am J Transplant"},{"issue":"2","key":"srv230009r23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000443169","article-title":"ENETS 2016 consensus guidelines for the management of patients with digestive neuroendocrine tumors: an update.","volume":"103","author":"O\u2019Toole","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"7","key":"srv230009r25","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/tri.2010.23.issue-7","article-title":"Liver transplantation for cholangiocarcinoma.","volume":"23","author":"Rosen","year":"2010","journal-title":"Transpl Int"},{"issue":"2","key":"srv230009r26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.suc.2018.12.009","article-title":"Role of transplant in biliary disease.","volume":"99","author":"Romine","year":"2019","journal-title":"Surg Clin North Am"},{"issue":"3","key":"srv230009r27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","article-title":"Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma.","volume":"242","author":"Rea","year":"2005","journal-title":"Ann Surg"},{"issue":"10","key":"srv230009r28","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1002\/(ISSN)1527-6473","article-title":"Transplantation for hilar cholangiocarcinoma.","volume":"10","author":"Heimbach","year":"2004","journal-title":"Liver Transpl"},{"issue":"2","key":"srv230009r29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.gtc.2018.01.002","article-title":"Liver transplant for cholangiocarcinoma.","volume":"47","author":"Zamora-Valdes","year":"2018","journal-title":"Gastroenterol Clin North Am"},{"issue":"5","key":"srv230009r30","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/SLA.0000000000002574","article-title":"Transplantation versus resection for hilar cholangiocarcinoma: an argument for shifting treatment paradigms for resectable disease.","volume":"267","author":"Ethun","year":"2018","journal-title":"Ann Surg"},{"issue":"1","key":"srv230009r31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11605-007-0335-4","article-title":"Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period.","volume":"12","author":"Becker","year":"2008","journal-title":"J Gastrointest Surg"},{"issue":"5","key":"srv230009r32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","article-title":"Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.","volume":"3","author":"Lunsford","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"srv230009r33","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/BF00299775","article-title":"Role of liver transplantation in the treatment of unresectable liver cancer.","volume":"19","author":"Pichlmayr","year":"1995","journal-title":"World J Surg"},{"issue":"3","key":"srv230009r34","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/ajt.12591","article-title":"\u201cVery early\u201d intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?","volume":"14","author":"Sapisochin","year":"2014","journal-title":"Am J Transplant"},{"issue":"4","key":"srv230009r35","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/hep.28744","article-title":"Liver transplantation for \u201cvery early\u201d intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment.","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"key":"srv230009r36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.12659\/AOT.895936","article-title":"Intrahepatic cholangiocarcinoma in the liver explant after liver transplantation: histological differentiation and prognosis.","volume":"21","author":"Takahashi","year":"2016","journal-title":"Ann Transplant"},{"issue":"3","key":"srv230009r37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/ctr.2013.27.issue-3","article-title":"Unrecognized intrahepatic cholangiocarcinoma: an analysis of 993 adult cirrhotic liver explants.","volume":"27","author":"Vallin","year":"2013","journal-title":"Clin Transplant"},{"issue":"3","key":"srv230009r38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.v71.3","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"srv230009r39","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.3390\/ijms22063093","article-title":"Liver transplantation for colorectal liver metastases: current management and future perspectives.","volume":"22","author":"Puia-Negulescu","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"srv230009r40","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/jso.v116.3","article-title":"Liver transplantation for unresectable colorectal liver metastases: a systematic review.","volume":"116","author":"Moris","year":"2017","journal-title":"J Surg Oncol"},{"issue":"6","key":"srv230009r41","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.jhep.2020.08.015","article-title":"Liver transplantation for secondary liver tumours: the difficult balance between survival and recurrence.","volume":"73","author":"Line","year":"2020","journal-title":"J Hepatol"},{"issue":"2","key":"srv230009r42","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/ajt.15682","article-title":"Selection criteria related to long-term survival following liver transplantation for colorectal liver metastasis.","volume":"20","author":"Dueland","year":"2020","journal-title":"Am J Transplant"},{"issue":"5","key":"srv230009r43","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/SLA.0b013e3182823957","article-title":"Liver transplantation for nonresectable liver metastases from colorectal cancer.","volume":"257","author":"Hagness","year":"2013","journal-title":"Ann Surg"},{"issue":"2","key":"srv230009r44","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/SLA.0000000000003404","article-title":"Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases.","volume":"271","author":"Dueland","year":"2020","journal-title":"Ann Surg"},{"issue":"12","key":"srv230009r45","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/bjs\/znab196","article-title":"Liver transplantation for advanced liver-only colorectal metastases.","volume":"108","author":"Dueland","year":"2021","journal-title":"Br J Surg"},{"issue":"11","key":"srv230009r46","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1111\/tri.v34.11","article-title":"Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases.","volume":"34","author":"Dueland","year":"2021","journal-title":"Transpl Int"},{"issue":"7","key":"srv230009r47","doi-asserted-by":"publisher","first-page":"842","DOI":"10.6002\/ect","article-title":"Liver transplant for nonresectable colorectal cancer liver metastases in South Africa: a single-center case series.","volume":"18","author":"Botha","year":"2020","journal-title":"Exp Clin Transplant"},{"issue":"3","key":"srv230009r48","doi-asserted-by":"publisher","first-page":"601","DOI":"10.21037\/jgo","article-title":"Liver transplantation in the treatment of unresectable hepatic metastasis from neuroendocrine tumors.","volume":"11","author":"Kim","year":"2020","journal-title":"J Gastrointest Oncol"},{"issue":"4","key":"srv230009r49","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jhep.2007.07.004","article-title":"Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?","volume":"47","author":"Mazzaferro","year":"2007","journal-title":"J Hepatol"},{"issue":"2","key":"srv230009r50","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000443167","article-title":"ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site.","volume":"103","author":"Pavel","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"1","key":"srv230009r51","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/S1470-2045(13)70362-0","article-title":"Recommendations for management of patients with neuroendocrine liver metastases.","volume":"15","author":"Frilling","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"srv230009r52","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.transproceed.2019.04.010","article-title":"Liver transplant for metastatic neuroendocrine tumors: a single-center experience in Hungary.","volume":"51","author":"Korda","year":"2019","journal-title":"Transplant Proc"},{"issue":"2","key":"srv230009r53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/jso.v112.2","article-title":"Liver transplantation for metastatic neuroendocrine tumors: outcomes and prognostic variables.","volume":"112","author":"Sher","year":"2015","journal-title":"J Surg Oncol"},{"issue":"6","key":"srv230009r54","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/j.1600-6143.2008.02233.x","article-title":"Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report.","volume":"8","author":"Le Treut","year":"2008","journal-title":"Am J Transplant"},{"issue":"5","key":"srv230009r55","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/SLA.0b013e31828ee17c","article-title":"Liver transplantation for neuroendocrine tumors in Europe, results and trends in patient selection: a 213-case European liver transplant registry study.","volume":"257","author":"Le Treut","year":"2013","journal-title":"Ann Surg"},{"issue":"3","key":"srv230009r56","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/(ISSN)1527-6473","article-title":"Liver transplantation for gastroenteropancreatic neuroendocrine cancers: defining selection criteria to improve survival.","volume":"12","author":"van Vilsteren","year":"2006","journal-title":"Liver Transpl"},{"issue":"3","key":"srv230009r57","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/(ISSN)1527-6473","article-title":"Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors.","volume":"13","author":"Olausson","year":"2007","journal-title":"Liver Transpl"},{"issue":"7","key":"srv230009r58","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/(ISSN)1527-6473","article-title":"Liver transplantation for patients with metastatic endocrine tumors: single-center experience with 15 patients.","volume":"12","author":"Frilling","year":"2006","journal-title":"Liver Transpl"},{"issue":"24","key":"srv230009r59","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1200\/JCO.22.00176","article-title":"Neuroendocrine tumors and peptide receptor radionuclide therapy: when is the right time?","volume":"40","author":"Hope","year":"2022","journal-title":"J Clin Oncol"},{"issue":"1","key":"srv230009r60","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40265-018-1033-0","article-title":"Targeted systemic treatment of neuroendocrine tumors: current options and future perspectives.","volume":"79","author":"Herrera-Mart\u00ednez","year":"2019","journal-title":"Drugs"},{"issue":"1","key":"srv230009r61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00261-019-02340-5","article-title":"Complications of liver transplant.","volume":"46","author":"Craig","year":"2021","journal-title":"Abdom Radiol (NY)"},{"issue":"6","key":"srv230009r62","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.06.1262","article-title":"Sonographic evaluation of venous obstruction in liver transplants.","volume":"188","author":"Chong","year":"2007","journal-title":"AJR Am J Roentgenol"},{"issue":"19","key":"srv230009r63","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.3748\/wjg.v19.i19.2841","article-title":"Biliary complications following liver transplantation.","volume":"19","author":"Kochhar","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"3","key":"srv230009r64","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/TP.0000000000002005","article-title":"Incidence and risk factors of intracranial hemorrhage in liver transplant recipients.","volume":"102","author":"Gallagher","year":"2018","journal-title":"Transplantation"},{"issue":"8","key":"srv230009r65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221626","article-title":"Cerebral metabolite alterations in patients with posttransplant encephalopathy after liver transplantation.","volume":"14","author":"Pflugrad","year":"2019","journal-title":"PLoS One"},{"key":"srv230009r66","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.920630","article-title":"Tracheostomy post liver transplant: predictors, complications, and outcomes.","volume":"25","author":"Graham","year":"2020","journal-title":"Ann Transplant"},{"issue":"5","key":"srv230009r67","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.5830\/CVJA-2016-032","article-title":"Takotsubo cardiomyopathy post liver transplantation.","volume":"27","author":"Vachiat","year":"2016","journal-title":"Cardiovasc J Afr"},{"issue":"11","key":"srv230009r68","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/lt.26094","article-title":"Post-liver transplant acute kidney injury.","volume":"27","author":"Dong","year":"2021","journal-title":"Liver Transpl"},{"issue":"3","key":"srv230009r69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011639.pub2","article-title":"Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.","volume":"3","author":"Rodr\u00edguez-Per\u00e1lvarez","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"srv230009r70","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list.","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"srv230009r71","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s10620-019-05549-y","article-title":"Liver allocation policies in the USA: past, present, and the future.","volume":"64","author":"Pillai","year":"2019","journal-title":"Dig Dis Sci"},{"key":"srv230009r22","unstructured":"OPTN\/UNOS Liver and Intestinal Organ Transplantation Committee. Briefing paper: liver review board guidance document. 2017. https:\/\/optn.transplant.hrsa.gov\/media\/2175\/liver_boardreport_guidance_201706.pdf."},{"key":"srv230009r24","unstructured":"National Comprehensive Cancer Network. Hepatobiliary Cancers (Version 2.2021). Published 2021. Accessed May 13, 2021. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hepatobiliary.pdf"},{"key":"srv230009r72","unstructured":"Organ Procurement and Transplantation Network. OPTN policies. Accessed October 30, 2023. https:\/\/optn.transplant.hrsa.gov\/media\/eavh5bf3\/optn-policies-effective-as-of-dec-6-2021-e-signature.pdf"},{"key":"srv230009r73","unstructured":"Organ Procurement and Transplantation Network. Guidance to liver transplant programs and the National Liver Review Board for adult MELD exceptions for hepatocellular carcinoma (HCC). Accessed October 30, 2023. https:\/\/optn.transplant.hrsa.gov\/media\/gqlnhrtn\/20200804_nlrb_adult_hcc_guidance.pdf"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2812759\/jamasurgery_gorji_2023_rv_230009_1707866527.90005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T11:02:29Z","timestamp":1707908549000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2812759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2023.6083","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}